Evaluating the Accuracy of Dynamic Navigation in Implant Surgery for Full Arch Prosthesis
Launched by UNIVERSITY OF MEDICINE AND PHARMACY AT HO CHI MINH CITY · Apr 30, 2025
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new system called the Dynamic Navigation System to see how accurately it can help place dental implants for patients who need a full arch prosthesis—essentially a complete set of replacement teeth. The trial will include two groups of patients: one group will have small bone screws placed in their jaw to guide the implant placement, while the other group will use their remaining healthy teeth as guides. The goal is to assess how well the implants are placed and to compare the effectiveness of both methods.
To be eligible for this study, you need to be at least 18 years old and either completely toothless or have some missing teeth. You should also be in good health overall. Participants can expect to undergo a surgical procedure where implants are placed, and they will be monitored for any complications or issues afterward. While there are some risks, like infection or slight increases in surgery time, the study will cover costs for certain aspects of the procedure. This research aims to improve dental implant methods for future patients, making it a valuable contribution to dental care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients who are fully edentulous or have partial edentulism and are in need of full arch prosthesis rehabilitation.
- • Aged 18 years and older.
- • Individuals in good general health (American Society of Anesthesiologists (ASA) class I or II)
- • Willing to participate in the study and provide informed consent.
- Exclusion Criteria:
- • Any serious medical (ASA class III or IV) or psychiatric conditions.
- • Pregnant or breastfeeding women.
- • General or Local Health Conditions Affecting Surgery: Systemic/local conditions that affect surgical healing, wound healing, and bone integration or use of medications such as steroids, bisphosphonates, or other drugs affecting bone health; smoking more than 10 cigarettes per day; acute infections at the planned implant site that have not been treated.
- • Patients with a limited mouth opening of less than 40mm.
About University Of Medicine And Pharmacy At Ho Chi Minh City
The University of Medicine and Pharmacy at Ho Chi Minh City is a premier academic institution dedicated to advancing healthcare education and research in Vietnam. Renowned for its commitment to excellence in medical training, the university actively engages in innovative clinical trials aimed at improving patient outcomes and addressing pressing health challenges. By leveraging its extensive network of healthcare professionals and state-of-the-art facilities, the institution fosters collaboration between researchers, clinicians, and industry partners, ensuring the translation of scientific discoveries into effective medical practices. Through its rigorous ethical standards and dedication to patient safety, the university plays a vital role in enhancing the quality of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ho Chi Minh City, , Vietnam
Ho Chi Minh City, , Vietnam
Patients applied
AV
DR
Trial Officials
Nhiem Cao Tran
Principal Investigator
University of Medicine and Pharmacy at Ho Chi Minh City
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported